Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity

Recruiting N/A Interventional Study
Alzheimer Disease, Early Onset Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 80
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
120 (estimated)
Sponsor
Rennes University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of the NODAL clinical trial is to demonstrate the feasibility of new, low-cost, non-invasive biomarkers of neurodegenerative pathologies as early Alzheimer and Parkinson, based on the estimation of the multimodal connectome.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * For all participants: * French mother tongue * right-handed * with a level of education equal to or higher than the Certificat d'Études Primaires (Primary School Certificate) * Free of any medical or psychiatric condition likely to interfere with cognition (excluding diagnosis…
Contacts

marie-laure gervais, Phd

299282555

marie-laure.gervais@chu-rennes.fr

CONTACT

Pierre-Yves JONIN, PhD

299284321

pierreyves.jonin@chu-rennes.fr

CONTACT